Health Catalyst (HCAT) Stock Statistics & Valuation Metrics

Health Catalyst has a market cap or net worth of $126.61M. The enterprise value is $95.41M.

Health Catalyst has 70,730,880 shares outstanding. The number of shares has decreased by -2.65% in one year.

Health Catalyst’s return on equity (ROE) is -0.72 and return on invested capital (ROIC) is -38.44%.

The current PE Ratio of Health Catalyst is ―. Health Catalyst’s PEG ratio is -0.00771.

In the last 12 months, Health Catalyst had revenue of 311.14M and earned -177.97M in profits. Earnings per share was -2.55.

In the last 12 months, operating cash flow was 731.00K and capital expenditures -5.52M, giving a free cash flow of -4.79M billion.

Health Catalyst pays an annual dividend of ―, resulting in a dividend yield of ―

Health Catalyst upcoming earnings date is May 12, 2026, After Close (Confirmed).

Health Catalyst as a current ratio of 1.89, with Debt / Equity ratio of 7.98%

In the past 12 months, Health Catalyst has paid 716.00K in taxes.

Health Catalyst EV to EBITDA ratio is -0.95, with an EV/FCF ratio of -573.21.

Health Catalyst has $95.73M in cash and marketable securities with $19.61M in debt, giving a net cash position of $76.12M billion.

Gross margin is 48.75%, with operating margin of -51.70%, and net profit margin of -57.20%.

The average price target for Health Catalyst is $2.79, which is 11.43% higher than the current price. The consensus rating is Moderate Buy